Costco’s June Sales Rose 8% From A Year Ago
Costco Wholesale has reported that its net sales rose 8% year-over-year in June to $26.4 billion U.S., up from a 6.8% gain in May. The June sales snap a string of five consecutive months of slowing sales growth at the warehouse club.Same-store sales at Costco, which measure sales growth at stores that have been open for more than a year, grew 5.8% in June from a year ago, compared with a 4.3% advance in May.Stripping out fluctuations in gas prices and foreign exchange rates, same-store sales increased 6.2%, also an improvement from May’s 6% growth.For accounting purposes, Costco’s “month of June” ended July 4, which means that June’s results include Father’s Day, Juneteenth, and the lead-up to the Independence Day holiday. Costco executives said categories that performed strongly in June include candy, meats and produce, basically the ingredients for a summer barbeque.Strong consumer demand from abroad also boosted Costco’s June results. Same-store sales excluding gas and foreign exchange rates rose 7.9% in Canada and 8.2% in the dozen or so other countries where Costco has warehouses. U.S. same-store sales grew 5.5% in June.Costco’s e-commerce business that comprises online sales registered an 11.2% increase.Consumers have continued to flock to Costco since the onset of the Covid-19 pandemic, lured by the company’s bulk pricing on groceries and other items such as gasoline.COST stock has risen 8% this year to trade at $982.09 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


